Rhythm Pharmaceuticals, Inc.
RYTM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $52 | $136 | $106 | $89 |
| Short-Term Investments | $364 | $155 | $208 | $231 |
| Receivables | $33 | $26 | $18 | $19 |
| Inventory | $0 | $19 | $19 | $19 |
| Other Curr. Assets | $46 | $25 | $18 | $16 |
| Total Curr. Assets | $495 | $361 | $369 | $374 |
| Property Plant & Equip (Net) | $0 | $4 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $6 | $6 | $6 | $6 |
| Long-Term Investments | $1 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $3 | $8 | $8 |
| Total NC Assets | $12 | $12 | $17 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $507 | $373 | $387 | $392 |
| Liabilities | – | – | – | – |
| Payables | $14 | $16 | $12 | $12 |
| Short-Term Debt | $1 | $4 | $0 | $0 |
| Tax Payable | -$53 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $1 |
| Other Curr. Liab. | $143 | $109 | $100 | $102 |
| Total Curr. Liab. | $104 | $129 | $112 | $116 |
| LT Debt | $150 | $255 | $4 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $103 | $0 | $108 | $108 |
| Total NC Liab. | $254 | $255 | $112 | $112 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $4 | $4 |
| Total Liabilities | $358 | $385 | $224 | $228 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $144 | $143 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,304 | -$1,251 | -$1,205 | -$1,155 |
| AOCI | -$1 | -$2 | -$0 | -$0 |
| Other Equity | $1,454 | $1,242 | $1,224 | $1,177 |
| Total Equity | $149 | -$12 | $163 | $165 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $507 | $373 | $387 | $392 |
| Net Debt | $99 | $124 | -$102 | -$85 |